Analytical Data
-
基因名
SHOX2
- Application
-
别名
Homeobox protein Og12X; OG 12; OG 12X; OG12; OG12X; OGI 2X; OGI2X; Paired related homeobox protein SHOT; Paired-related homeobox protein SHOT; Short stature homeobox 2; Short stature homeobox homolog; Short stature homeobox protein 2; SHOT; SHOX 2; SHOX homologous gene on chromosome 3; SHOX2; SHOX2_HUMAN
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
O60902
-
表达区间
1-331 aa
-
氨基酸序列
MEELTAFVSK SFDQKVKEKK EAITYREVLE SGPLRGAKEP TGCTEAGRDD RSSPAVRAAG GGGGGGGGGG GGGGGGGVGG GGAGGGAGGG RSPVRELDMG AAERSREPGS PRLTEVSPEL KDRKEDAKGM EDEGQTKIKQ RRSRTNFTLE QLNELERLFD ETHYPDAFMR EELSQRLGLS EARVQVWFQN RRAKCRKQEN QLHKGVLIGA ASQFEACRVA PYVNVGALRM PFQQDSHCNV TPLSFQVQAQ LQLDSAVAHA HHHLHPHLAA HAPYMMFPAP PFGLPLATLA ADSASAASVV AAAAAAKTTS KNSSIADLRL KAKKHAAALG L
-
分子量
34.9 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SHOX2, or Short Stature Homeobox 2, is a homeodomain-containing transcription factor that plays a critical role in the regulation of developmental processes, especially in craniofacial and limb development. Mutations or dysregulation of SHOX2 are associated with several congenital disorders, including skeletal dysplasia and various syndromes, highlighting its importance in normal physiological functions. The study of SHOX2 recombinant protein has gained interest due to its potential implications in understanding the underlying mechanisms of these developmental anomalies. Research into SHOX2 focuses on its interaction with target genes and the proteins involved in signaling pathways that govern embryonic development. By producing and characterizing recombinant SHOX2, researchers aim to elucidate its functional domains, identify interacting partners, and explore its role in gene regulation. Furthermore, insights gained from studying SHOX2 can inform potential therapeutic approaches for related genetic disorders that arise from SHOX2 mutations. This ongoing research underscores the significance of SHOX2 in both developmental biology and clinical genetics, with the hope of advancing our knowledge and treatment strategies for conditions associated with SHOX2 dysfunction.
